SHANGHAI, China, Oct. 31 /Xinhua-PRNewswire/ -- Sundia MediTech Company, a Shanghai-based drug discovery and pharmaceutical development outsourcing service company (CRO) received this year's Deloitte Technology Fast 50 China award, and ranked number 16. The result of Deloitte Technology Fast 50 China Program was announced today in Shenzhen, China at a special ceremony.
Deloitte Technology Fast 50 Program started in 1995 in San Jose. This program quickly expanded to numerous cities and countries. In 2005, Deloitte China launched the "Deloitte Technology Fast 50 China" program. Participants in the Deloitte Technology Fast 50 China program will automatically qualify for participation in the Deloitte Technology Fast 500 Asia Pacific 2008 program, which annually recognises the 500 fastest growing technology companies in Asia Pacific.
Sundia was named consecutively in 2007 and 2008 as one of the top 50 most valuable companies for investment in China. About the Deloitte Technology Fast award, Dr. Xiaochuan Wang, Sundia's CEO said "it is another recognition of Sundia's achievement, and also recognition of China's CRO industry development."
Sudia has kept a high speed for business growth in the 4 and half year history of the company. Last year, Sundia successfully merged with another CRO company United Pharmatech Company in Shanghai. According to Dr. Shi Xiongwei, the founder of United Pharmatech and now Executive VP of Sundia, the company has expanded its business scope from the original chemistry service area to cover most drug discovery and pharmaceutical development areas. The company has made significant contribution to some new drug development programs for clients. Through closely working with client companies, they have successfully advanced a few programs to preclinical or clinical stage.
Sundia's CFO Mr. Beijia Yu and Vice President Dr. Jiong Chen attended today's ceremony to receive "Deloitte Technology Fast 50 China" award.
About the Company
Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 4 years, Sundia has built a strong reputation in its field.
